Artelo Biosciences Files 8-K with Corporate Updates

TL;DR

ARTL filed an 8-K on 9/9/25 for corporate updates and financials.

AI Summary

Artelo Biosciences, Inc. filed an 8-K on September 9, 2025, reporting amendments to its Articles of Incorporation or Bylaws and submitting financial statements and exhibits. The company, incorporated in Nevada, operates in the Pharmaceutical Preparations sector and is located in Solana Beach, California.

Why It Matters

This filing indicates potential changes in the company's corporate structure or governance, which could impact its operational direction and investor relations.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain significant negative news or events.

Key Players & Entities

• ARTELO BIOSCIENCES, INC. (company) — Registrant
• September 9, 2025 (date) — Date of earliest event reported
• Nevada (jurisdiction) — State of incorporation
• Solana Beach, CA (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share ARTL The Nasdaq Stock Mar

Filing Documents

• artl_8k.htm (8-K) — 29KB
• artl_ex31.htm (EX-3.1) — 6KB
• 0001640334-25-001660.txt ( ) — 157KB
• artl-20250909.xsd (EX-101.SCH) — 5KB
• artl-20250909_lab.xml (EX-101.LAB) — 15KB
• artl-20250909_cal.xml (EX-101.CAL) — 1KB
• artl-20250909_pre.xml (EX-101.PRE) — 10KB
• artl-20250909_def.xml (EX-101.DEF) — 2KB
• artl_8k_htm.xml (XML) — 4KB

03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 9, 2025, the board of directors (the "Board") of Artelo Biosciences, Inc. (the "Company") amended the Company's amended and restated bylaws, as provided in a Certificate of Amendment to Bylaws (the "Bylaws Amendment"), as follows: The required notice period for special meetings of the Board has been updated, as provided in the Bylaws Amendment; The right of stockholders to take action without a meeting has been eliminated; The Bylaws have been updated to provide that the Company shall in all respects be considered an "issuing corporation" for purposes of the provisions of NRS 78.378 to 78.3793 inclusive, irrespective of whether the Company, as of any date, (i) has 200 or more stockholders of record, at least 100 of whom have had addresses in Nevada appearing on the stock ledger of the Company at all times during the 90 days immediately preceding such date, and/or (ii) does business in Nevada directly or through an affiliated corporation; and The Bylaws have been updated to provide that the record date for determining shareholders entitled (i) to notice of or to vote at any shareholders' meeting or adjournment thereof, (ii) to receive payment of any share dividend, or (iii) to receive payment of any distribution shall be not more than 60 days prior to the date on which the particular action requiring determination of shareholders is to be taken. The Bylaws Amendment is filed as Exhibit 3.1 hereto and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Exhibit 3.1 Certificate of Amendment to Bylaws 104 Cover Page Interactive Data File (embedded within the XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARTELO BIOSCIENCES, INC. Date: September 10, 2025 /s/ Gregory D. Gorgas Gregory D. Gorgas President & Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR